Are we living in the "Golden Age of Medicine"? That's what the New York Times just proposed. Between CRISPR-powered therapies, mRNA applications, and other biotech advancements, we have remarkably effective treatments for everything from breast cancer to obesity in final approval stages, and experts say that this may be just the beginning.
These breakthroughs could transform our life expectancy expectations, and drive an unprecedented dependence on excellent financial decision-making.
In this 45-minute webinar, we brought together longevity and financial experts for this special session on the implications of this Medical Golden Age.